<code id='C819498AD4'></code><style id='C819498AD4'></style>
    • <acronym id='C819498AD4'></acronym>
      <center id='C819498AD4'><center id='C819498AD4'><tfoot id='C819498AD4'></tfoot></center><abbr id='C819498AD4'><dir id='C819498AD4'><tfoot id='C819498AD4'></tfoot><noframes id='C819498AD4'>

    • <optgroup id='C819498AD4'><strike id='C819498AD4'><sup id='C819498AD4'></sup></strike><code id='C819498AD4'></code></optgroup>
        1. <b id='C819498AD4'><label id='C819498AD4'><select id='C819498AD4'><dt id='C819498AD4'><span id='C819498AD4'></span></dt></select></label></b><u id='C819498AD4'></u>
          <i id='C819498AD4'><strike id='C819498AD4'><tt id='C819498AD4'><pre id='C819498AD4'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:Wikipedia    Page View:4514
          A box of Sudafed PE sinus pressure and pain medicine. -- health coverage from stat
          PATRICK T. FALLON/AFP via Getty Images

          You would have been forgiven for being surprised on Sept. 12 when a panel of advisers to the Food and Drug Administration concluded that the active ingredient in Sudafed PE and other over-the-counter decongestants is completely ineffective. It was front-page news, birthed myriad explainer stories on the internet, and even inspired a lawsuit against companies that sold the medicine, phenylephrine.

          Yet when T.J. Parker, the entrepreneur and pharmacist who sold PillPack to Amazon, saw the news, he tweeted, “Didn’t everyone know this?”

          advertisement

          He had a point.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Hollywood unions extend contract negotiations for actors
          Hollywood unions extend contract negotiations for actors

          1:36HollywoodwritersandtheirsupportersfromtheSAGAFTRAactors'unionwalkthepicketlineoutsideWarnerBrosS

          read more
          Europe sees delivery challenges ahead on Alzheimer's therapies
          Europe sees delivery challenges ahead on Alzheimer's therapies

          VialsandpackagingforLeqembi,anewAlzheimer'smedicationapprovedintheU.S.,butnotyetinEurope.Illustratio

          read more
          Virginia high school admissions case could be legal follow
          Virginia high school admissions case could be legal follow

          3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

          read more

          More regulation could be coming for drug ads

          AdobeWASHINGTON—Governmentregulatorsmaysoondecidewhethertocrackdownondistractingvisualsintelevisiond